FDA plans ultra-fast review of three psychedelic drugs following Trump directive?
FDA to expedite review of three psychedelic drugs, potentially transforming mental health treatment.
Setiap kartu di bawah mengarah ke halaman detail artikel (HTML) di jalur kategori yang sama.
Baca pasar ekuitas: saham unggulan, sektor, valuasi, arus dana, dan sentimen perdagangan.
FDA to expedite review of three psychedelic drugs, potentially transforming mental health treatment.
Berita market harian, pergerakan sektor, saham, dan sentimen perdagangan yang relevan.
FDA to expedite review of three psychedelic drugs, potentially transforming mental health treatment.
L3Harris Technologies Inc (NYSE:LHX – Get Free Report) announced a quarterly dividend on Thursday, April 23rd. Investors of record on Friday, June 5th will be given a dividend of 1.25 per share on Friday, June 26th. T...